|
25.02.2014 12:05:00
|
Moody's: AbbVie, Amgen and Roche most exposed to biosimilar drugs market
New York, February 25, 2014 -- Companies are racing to expand the global biosimilar drugs market, Moody's Investors Service says in a new report, "Biosimilars: Parsing the Industry's Pipelines." And while biosimilar products have been launched in Asia and Europe, they are at least three years away in the US, the world's largest pharmaceutical market.
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.